Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 16;399(10334):1551-1560.
doi: 10.1016/S0140-6736(22)00306-3.

Improved models of care for cancer survivors

Affiliations
Review

Improved models of care for cancer survivors

Michael Jefford et al. Lancet. .

Abstract

The number of survivors of cancer is increasing substantially. Current models of care are unsustainable and fail to address the many unmet needs of survivors of cancer. Numerous trials have investigated alternate models of care, including models led by primary-care providers, care shared between oncology specialists and primary-care providers, and care led by oncology nurses. These alternate models appear to be at least as effective as specialist-led care and are applicable to many survivors of cancer. Choosing the most appropriate care model for each patient depends on patient-level factors (such as risk of longer-term effects, late effects, individual desire, and capacity to self-manage), local services, and health-care policy. Wider implementation of alternative models requires appropriate support for non-oncologist care providers and endorsement of these models by cancer teams with their patients. The COVID-19 pandemic has driven some changes in practice that are more patient-centred and should continue. Improved models should shift from a predominant focus on detection of cancer recurrence and seek to improve the quality of life, functional outcomes, experience, and survival of survivors of cancer, reduce the risk of recurrence and new cancers, improve the management of comorbidities, and reduce costs to patients and payers. This Series paper focuses primarily on high-income countries, where most data have been derived. However, future research should consider the applicability of these models in a wider range of health-care settings and for a wider range of cancers.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests DH reports personal fees and other support from Carevive and personal fees from York University (Toronto, ON, Canada), outside the submitted work.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
    1. National Research Council . The National Academies Press; Washington, DC: 2005. From cancer patient to cancer survivor: lost in transition.
    1. WHO . World Health Organization; Geneva: 2017. Health employment and economic growth: an evidence base.
    1. Alfano CM, Jefford M, Maher J, Birken SA, Mayer DK. Building personalized cancer follow-up care pathways in the United States: lessons learned from implementation in England, Northern Ireland, and Australia. Am Soc Clin Oncol Educ Book. 2019;39:625–639. - PubMed
    1. Farrington CJ. Co-designing healthcare systems: between transformation and tokenism. J R Soc Med. 2016;109:368–371. - PMC - PubMed

Uncited Reference

    1. Takahashi M. Cancer survivorship: current status of research, care, and policy in Japan. Jpn J Clin Oncol. 2016;46:599–604. - PubMed

Publication types